ViewRay Inc
OTC:VRAYQ

Watchlist Manager
ViewRay Inc Logo
ViewRay Inc
OTC:VRAYQ
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $183

ViewRay Inc
Accounts Receivables

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

ViewRay Inc
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
ViewRay Inc
OTC:VRAYQ
Accounts Receivables
$47.5m
CAGR 3-Years
30%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Accounts Receivables
$2.9B
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
9%
Edwards Lifesciences Corp
NYSE:EW
Accounts Receivables
$659.6m
CAGR 3-Years
-3%
CAGR 5-Years
2%
CAGR 10-Years
5%
Stryker Corp
NYSE:SYK
Accounts Receivables
$4B
CAGR 3-Years
4%
CAGR 5-Years
8%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Accounts Receivables
$7.9B
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
9%
Intuitive Surgical Inc
NASDAQ:ISRG
Accounts Receivables
$1.5B
CAGR 3-Years
17%
CAGR 5-Years
19%
CAGR 10-Years
15%
No Stocks Found

ViewRay Inc
Glance View

Market Cap
183 USD
Industry
Health Care

ViewRay, Inc. designs, manufactures and markets magnetic resonance imaging (MRI) system. The company is headquartered in Oakwood Village, Ohio and currently employs 267 full-time employees. The company went IPO on 2014-11-04. The MRIdian MR-Guided Radiation Therapy System integrates diagnostic MR imaging with radiation therapy delivery to enable on-table adaptive treatments with real-time tissue tracking and automatic beam gating. The MRIdian is comprised of three components, namely magnetic resonance imaging (MRI) system, radiation delivery system, and integrated treatment planning and delivery software. MRIdian employs MRI-based technology to provide real-time imaging that targets tumor from the surrounding soft tissue and other critical organs, both before and during radiation treatment delivery. MRIdian offers MR-guided imaging that provides tissue visualization compared to cone-beam computed tomography (CBCT), to enable contouring and reduced margins. The firm has installed approximately 48 MRIdian systems at hospitals, which are used to treat a variety of solid tumors.

VRAYQ Intrinsic Value
Not Available

See Also

What is ViewRay Inc's Accounts Receivables?
Accounts Receivables
47.5m USD

Based on the financial report for Mar 31, 2023, ViewRay Inc's Accounts Receivables amounts to 47.5m USD.

What is ViewRay Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
13%

Over the last year, the Accounts Receivables growth was 70%. The average annual Accounts Receivables growth rates for ViewRay Inc have been 30% over the past three years , 13% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett